# Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC

> **NCT00158652** · PHASE3 · COMPLETED · sponsor: **Groupe Oncologie Radiotherapie Tete et Cou** · enrollment: 840 (actual)

## Conditions studied

- Oral Cancer
- Oropharynx Cancer
- Hypopharynx Cancer
- Larynx Cancer

## Interventions

- **PROCEDURE:** Conventional radiotherapy 70 Gy in 7 weeks
- **PROCEDURE:** middle accelerated radiotherapy 70 Gy in 6 weeks
- **PROCEDURE:** very accelerated radiotherapy 64.8 Gy in 3.5 weeks
- **DRUG:** 5FU, Paraplatin

## Key facts

- **NCT ID:** NCT00158652
- **Lead sponsor:** Groupe Oncologie Radiotherapie Tete et Cou
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 840 (ACTUAL)
- **Last updated:** 2011-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158652, "Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00158652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*